Market Closed -
OTC Markets
01:28:15 18/07/2024 am IST
5-day change
1st Jan Change
0.2613
USD
-1.54%
+0.50%
+55.54%
BioLargo, Inc. announced that it has received $0.24 million in funding
On January 11, 2017, BioLargo, Inc. (OTCPK:BLGO) closed the transaction. The company received $242,000 from four investors.
BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion
11/06
CI
Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024
15/05
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
15/05
CI
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
03/04
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
02/04
CI
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
12/02
CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
29/01
CI
BioLargo, Inc. announced that it has received $0.815 million in funding
23/01
CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
20/12
CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
13/12
CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
21/11
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
17/11
CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023
17/23/17
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
15/23/15
CI
Transcript : BioLargo, Inc., Q1 2023 Earnings Call, May 18, 2023
19/23/19
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
17/23/17
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Apr 03, 2023
04/23/04
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
01/23/01
CI
BioLargo, Inc. Auditor Raises 'Going Concern' Doubt
31/23/31
CI
Biolargo, Inc. Announces Revenue Results for the Year 2022
09/23/09
CI
BioLargo, Inc. announced that it expects to receive $10 million in funding from Lincoln Park Capital, LLC
13/22/13
CI
Biolargo, Inc. Announces That the Pooph™ Pet Odor Control Product Line Is Now Available At Select Walmart Stores
22/22/22
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Nov 16, 2022
17/22/17
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
15/22/15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment engaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is engaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.
More about the company
Last Close Price
0.2613
USD
Average target price
0.35
USD
Spread / Average Target
+33.95%
Consensus
1st Jan change
Capi.
+55.54% 77.66M +2.88% 104B -5.63% 63.03B +85.24% 52.26B +7.15% 35.59B +3.85% 32.15B +7.40% 19.33B +16.25% 17.29B +8.88% 13.9B +74.66% 12.75B
Other Commodity Chemicals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOLARGO, INC. 
